DK1140103T3 - Ponazuril til behandling af neurologiske og abortfremkaldende sygdomme forårsaget af Coccidia - Google Patents

Ponazuril til behandling af neurologiske og abortfremkaldende sygdomme forårsaget af Coccidia

Info

Publication number
DK1140103T3
DK1140103T3 DK99968140T DK99968140T DK1140103T3 DK 1140103 T3 DK1140103 T3 DK 1140103T3 DK 99968140 T DK99968140 T DK 99968140T DK 99968140 T DK99968140 T DK 99968140T DK 1140103 T3 DK1140103 T3 DK 1140103T3
Authority
DK
Denmark
Prior art keywords
ponazuril
coccidia
abortion
neurological
treatment
Prior art date
Application number
DK99968140T
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK1140103T3 publication Critical patent/DK1140103T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99968140T 1998-12-22 1999-12-18 Ponazuril til behandling af neurologiske og abortfremkaldende sygdomme forårsaget af Coccidia DK1140103T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/218,323 US6150361A (en) 1998-12-22 1998-12-22 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
PCT/US1999/030281 WO2000037063A2 (en) 1998-12-22 1999-12-18 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (1)

Publication Number Publication Date
DK1140103T3 true DK1140103T3 (da) 2005-12-19

Family

ID=22814646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99968140T DK1140103T3 (da) 1998-12-22 1999-12-18 Ponazuril til behandling af neurologiske og abortfremkaldende sygdomme forårsaget af Coccidia

Country Status (17)

Country Link
US (1) US6150361A (da)
EP (1) EP1140103B1 (da)
JP (1) JP2002532544A (da)
KR (1) KR100661111B1 (da)
CN (1) CN1221265C (da)
AT (1) ATE302011T1 (da)
AU (1) AU764608B2 (da)
BR (1) BR9916391A (da)
CA (1) CA2355825C (da)
DE (1) DE69926794T2 (da)
DK (1) DK1140103T3 (da)
ES (1) ES2247863T3 (da)
HK (1) HK1045266B (da)
HU (1) HUP0104595A3 (da)
NZ (1) NZ512477A (da)
WO (1) WO2000037063A2 (da)
ZA (1) ZA200103920B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000019964A2 (en) 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
CA2407517A1 (en) * 2000-04-25 2001-11-01 Wyeth Equine protozoal myeloencephalitis vaccine
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4933341A (en) * 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
WO2000019964A2 (en) * 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease

Also Published As

Publication number Publication date
HK1045266B (zh) 2006-07-07
NZ512477A (en) 2004-05-28
CA2355825C (en) 2008-07-08
US6150361A (en) 2000-11-21
DE69926794D1 (de) 2005-09-22
ES2247863T3 (es) 2006-03-01
KR20010080570A (ko) 2001-08-22
ATE302011T1 (de) 2005-09-15
EP1140103A2 (en) 2001-10-10
EP1140103B1 (en) 2005-08-17
HUP0104595A3 (en) 2003-10-28
CA2355825A1 (en) 2000-06-29
HUP0104595A2 (hu) 2002-04-29
WO2000037063A3 (en) 2000-10-19
AU2481700A (en) 2000-07-12
ZA200103920B (en) 2002-05-15
HK1045266A1 (en) 2002-11-22
CN1221265C (zh) 2005-10-05
AU764608B2 (en) 2003-08-28
BR9916391A (pt) 2001-09-18
KR100661111B1 (ko) 2006-12-26
JP2002532544A (ja) 2002-10-02
WO2000037063A2 (en) 2000-06-29
CN1342081A (zh) 2002-03-27
DE69926794T2 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
EA200701296A1 (ru) 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
LU91254I2 (fr) Daptomycine et ses dérivés pharmaceutiquement acceptables (cubicinr)
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
MY119375A (en) Treatment of tinnitus using neuroprotective agents
EA200100750A1 (ru) Способ лечения сексуальных нарушений
HK1043315A1 (en) Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma.
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
GB0130677D0 (en) Medicaments and novel compounds
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
EE9900275A (et) CD40L-vastaste ühendite terapeutilise manustamise meetodid
DK1140103T3 (da) Ponazuril til behandling af neurologiske og abortfremkaldende sygdomme forårsaget af Coccidia
DE69300321D1 (de) Behandlung neurodegenerativer Erkrankungen.
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
DK1296686T3 (da) Praziquanatelsammensætninger til behandling af coccidiesygdomme
ATE248607T1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.